<p><b>TABLE OF INTERACTIONS WITH</b></p>

<p><b>STIRIPENTOL </b></p>

<p><b>From the French ANSM drug interactions document of </b></p>

<p><b>September 2016, pp. 202-203</b></p>

<table cellspacing="0" cellpadding="0" border="1">
<tbody>
<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>ANTICONVULSANT ENZYMATIC INDUCERS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>N03A-001</b></p></td>
<td valign="top"><p>Increase of the plasma concentrations of the anticonvulsant, with risk of overdose, due to inhibition of its hepatic metabolism by the stiripentol</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and plasma dosage, when that is possible, of the anticonvulsant taken with the stiripentol, and possible adjustment of its dosage<b>. </b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>ATORVASTATIN</b></p>

<p><b>RxNorm: 83367 </b></p>

<p><b>ATC: C10AA05</b></p></td>
<td valign="top"><p>Increased risk of undesirable effects (dose dependent) of the rhabdomyolysis type (decrease of the hepatic metabolism of the chlosterol lowering medication)</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>CAFFEINE </b></p>

<p><b>RxNorm: 1886</b></p>

<p><b>ATC: N06BC01 V04CG30</b></p></td>
<td valign="top"><p>Possible increase of the plasma concentrations of the caffeine, with risk of overdose, due to inhibition of its hepatic metabolism</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and possible adjustment of the dosage of caffeine<b>. </b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>CLOBAZAM</b></p>

<p><b>RxNorm: 21241</b></p>

<p><b>ATC: N05BA09</b></p></td>
<td valign="top"><p>Increase of the plasma concentrations of these anticonvulsants, with risk of overdose, due to inhibition of their hepatic metabolism</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring, plasma dosage, when that is possible, of the anticonvulsant taken with the stiripentol, and possible adjustment of the dosage of that anticonvulsant as well.</p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>DIAZEPAM</b></p>

<p><b>RxNorm: 3322</b></p>

<p><b>ATC: N05BA01</b></p></td>
<td valign="top"><p>Increase of the plasma concentrations of the diazepam, with risk of overdose, due to inhibition of its hepatic metabolism</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and plasma dosage, when that is possible, of the anticonvulsant taken with the stiripentol, and possible adjustment of the dosage of the anticonvulsant as well.</p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>DIHYDROERGOTAMINE</b></p>

<p><b>RxNorm: 3418 </b></p>

<p><b>ATC: N02CA01</b></p></td>
<td valign="top"><p>Ergotism with possibility of necrosis of the extremities (inhibition of the hepatic elimination of the alkaloid of ergot of rye)</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>ERGOTAMINE</b></p>

<p><b>RxNorm: 4025 </b></p>

<p><b>ATC: N02CA02</b></p></td>
<td valign="top"><p>Ergotism with possibility of necrosis of the extremities (inhibition of the hepatic elimination of the alkaloid of ergot of rye)</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>HALOFANTRINE</b></p>

<p><b>RxNorm: 50749</b></p>

<p><b>ATC: P01BX01</b></p></td>
<td valign="top"><p>Increased risk of ventricular arrhythmias, especially of torsades de pointes. </p></td>
<td valign="top"><p><b>Not recommended</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>IMMUNOSUPPRESSANTS</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>L04A</b></p></td>
<td valign="top"><p>Increase of the blood concentrations of the immunosuppressant (decrease of its hepatic metabolism)</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>MIDAZOLAM</b></p>

<p><b>RxNorm: 6960</b></p>

<p><b>ATC: N05CD08</b></p></td>
<td valign="top"><p>Increase of the plasma concentrations of the midazolam due to decrease of its hepatic metabolism with increase of sedation</p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring and reduction of the dosage during the treatment with the stiripentol<b>.</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>PIMOZIDE</b></p>

<p><b>RxNorm: 8331</b></p>

<p><b>ATC: N05AG02 </b></p></td>
<td valign="top"><p>Increased risk of ventricular arrhythmias, especially of torsades de pointes</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>QUINIDINE</b></p>

<p><b>RxNorm: 9068 </b></p>

<p><b>ATC: C01BA01 </b></p></td>
<td valign="top"><p>Increased risk of ventricular arrhythmias, especially of torsades de pointes</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p></td>
<td valign="top"><p><b>SIMVASTATIN</b></p>

<p><b>RxNorm: 36567 </b></p>

<p><b>ATC: C10AA01</b></p></td>
<td valign="top"><p>Increased risk of undesirable effects (dose dependent) of the rhabdomyolysis type (decrease of the hepatic metabolism of the cholesterol lowering agent)</p></td>
<td valign="top"><p><b>CONTRAINDICATION</b></p></td>
</tr>

<tr>
<td valign="top"><p><b>STIRIPENTOL</b></p>

<p><b>RxNorm: 37119</b></p>

<p><b>ATC: N03AX17</b></p>

</td>
<td valign="top"><p><b>THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)</b></p>

<p><b>CLASS CODE: </b></p>

<p><b>R03DA</b></p></td>
<td valign="top"><p>Possible increase of the theophyllinemia, with risk of overdose, due to inhibition of its hepatic metabolism </p></td>
<td valign="top"><p><b>Precaution for use</b></p>

<p>Clinical monitoring, plasma dosage, and possible adjustment of the dosage of theophylline<b>.</b></p></td>
</tr>

</tbody>
</table>

